Pura Vida Investments, LLC's Form 4 filing
Insight Molecular Diagnostics Inc. (IMDX) · filed Apr 18, 2022
- Accession no.
- 0001829126-22-008372
- Filed
- Apr 18, 2022, 9:55 PM ET
- Trade date
- Apr 14, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 8 non-derivative transactions and 4 derivative transactions. Open-market purchases total $7.89M. It was filed 4 days after the trade.
This filing was later replaced by the amendment 0001829126-22-009190 (Apr 29, 2022). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Pura Vida Investments, LLCCIK 0001590144 | 10% Owner |
| Kamen EfremCIK 0001789193 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 14, 2022 | Common Stock | PPurchaseAcquired | +1,665,898 | $1.33 | +$2,219,809.09 | 7,350,447 | Indirect | |
| Apr 14, 2022 | Common Stock | PPurchaseAcquired | +30,790 | $1.23 | +$37,779.33 | 7,381,237 | Indirect | |
| Apr 14, 2022 | Common Stock | PPurchaseAcquired | +92,370 | $1.26 | +$116,386.2 | 7,473,607 | Indirect | |
| Apr 14, 2022 | Common Stock | PPurchaseAcquired | +1,916,419 | $1.33 | +$2,553,628.32 | 8,455,823 | Indirect | |
| Apr 14, 2022 | Common Stock | PPurchaseAcquired | +19,210 | $1.23 | +$23,570.67 | 8,475,033 | Indirect | |
| Apr 14, 2022 | Common Stock | PPurchaseAcquired | +57,630 | $1.26 | +$72,613.8 | 8,532,663 | Indirect | |
| Apr 14, 2022 | Common Stock | PPurchaseAcquired | +767,952 | $1.33 | +$1,023,296.04 | 767,952 | Indirect | |
| Apr 14, 2022 | Common Stock | PPurchaseAcquired | +1,381,438 | $1.33 | +$1,840,766.14 | 1,381,438 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 14, 2022 | Common Stock | PPurchaseAcquired | +832,949 | –F1 | – | 832,949 | Indirect | |
| Apr 14, 2022 | Common Stock | PPurchaseAcquired | +383,976 | –F1 | – | 383,976 | Indirect | |
| Apr 14, 2022 | Common Stock | PPurchaseAcquired | +690,719 | –F1 | – | 690,719 | Indirect | |
| Apr 14, 2022 | Common Stock | PPurchaseAcquired | +958,209 | –F1 | – | 958,209 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Each share of common stock was purchased together with one warrant to purchase 0.5 shares of common stock at a combined offering price of $1.3325.
Referenced by the price of 4 transactions in Table II.